MS Brain Health Report 2024: Launch Videos
Brain health - time matters
Brain health - time matters
Welcome to our launch event video gallery for the 'Brain health – time matters' report. We are excited to share with you a full video of the launch event as well as a separate video that allows you to skip straight to the panel discussion.
About the Report
The Brain health - time matters report focuses on the latest advancements in understanding and managing multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). Our goal is to provide valuable insights and practical recommendations to improve brain health and patient outcomes.
Watch the Launch Videos
Explore our launch videos featuring expert discussions, patient stories, and highlights from the report. These videos are designed to provide you with a comprehensive overview of the report's key messages and actionable steps for improving brain health.
Get Involved
We encourage you to share these videos with your network and join the conversation on social media using the hashtags #BrainHealth, #MSBH, and #OHPF. Together, we can make a difference in the lives of those affected by MS and related conditions.
Full length launch video
Panel discussion
The launch event was held on 19 September in Copenhagen and online, featuring insightful discussions from world-leading experts including Sumaira Ahmed, Helmut Butzkueven, Gavin Giovannoni, Anne Helme, Elisabeth Kasilingam, and Mitzi J Williams. Follow us on social media to see videos from the launch event.
Spread the word:
We welcome online engagement. Please use the following hashtags when posting about the report:
#BrainHealthTM #BrainHealth #MSBH #OHPF #MSTimeMatters #NMOSDTimeMatters #MOGADTimeMatters
The report has been supported by a grant from F. Hoffman-La Roche Ltd, which has had no control over the educational content of this activity. Grant funding has also been provided by the Multiple Sclerosis Society, which has contributed to the report as an author. Horizon, now part of Amgen, provided sponsorship for the development of this report and has had no control over the educational content.
The launch of this report has been sponsored by Merck Healthcare KGaA and Alexion Pharma GmbH; they have had no influence on the content of the launch event nor the report.
